Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CyberArk Software Gets Price Target Hikes By Analysts After Q1 Results

CyberArk Software Ltd (NASDAQ: CYBR) reported a narrower-than-expected loss for its first quarter.
byLisa Levin
May 12, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

CyberArk Software Ltd (NASDAQ:CYBR) reported a narrower-than-expected loss for its first quarter.

CyberArk Software reported first-quarter FY23 revenue growth of 27% year-on-year to $161.7 million, missing the consensus of $162.5 million. Non-GAAP EPS loss of $(0.17) beat the consensus loss of $(0.26).

CyberArk raised the non-GAAP EPS outlook to $0.16 – $0.38, up from $0.07 – $0.28 versus the consensus of $0.16.

CyberArk shares rose 3.9% to close at $142.71 on Thursday and lost 0.4% in after-hours trading.

These analysts made changes to their price targets on CyberArk following earnings announcement.

  • Needham raised the price target on CyberArk from $180 to $185. Needham analyst Alex Henderson maintained a Buy rating.
  • Barclays increased the price target on CyberArk from $175 to $178. Barclays analyst Saket Kalia maintained an Overweight rating
  • Rosenblatt analyst Catharine Trebnick, meanwhile, reiterated CyberArk Software with a Buy and maintained a $175 price target.

 

Read More: Investor Sentiment Declines Further After Dow Drops For Fourth Consecutive Day

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say ‘There’s No Stepping Back’ From Legalization Wave

By Jelena Martinovic
April 17, 12:28 PM
Flora Growth Corp. has entered into a definitive agreement to acquire all of the issued and outstanding shares of Hamburg, Germany-based TruHC Pharma GmbH. The company's latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into effect on April 1, which partially legalized cannabis. The new law allows adults over 18 in Germany to legally possess up to 25 grams of dried cannabis and cultivate up to three marijuana plants at home.As previously announced, Flora agreed to purchase TruHC Pharma GmbH in an all-stock deal in exchange for 2,770,562 of its common shares, valued at $6.4 million.

ACB